{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:42:45Z","timestamp":1788385365841,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invariant NKT (iNKT) cells comprise a heterogeneous group of non-circulating, tissue-resident T lymphocytes that recognize glycolipids, including alpha-galactosylceramide (\u03b1GalCer), in the context of CD1d, but whether peripheral iNKT cell subsets are terminally differentiated remains unclear. Here we show that mouse and human liver-resident \u03b1GalCer\/CD1d-binding iNKTs largely correspond to a novel Zbtb16<jats:sup>+<\/jats:sup>Tbx21<jats:sup>+<\/jats:sup>Gata3<jats:sup>+<\/jats:sup>Maf<jats:sup>low<\/jats:sup>Rorc<jats:sup>\u2013<\/jats:sup> subset that exhibits profound transcriptional, phenotypic and functional plasticity. Repetitive in vivo encounters of these liver iNKT (LiNKT) cells with intravenously delivered \u03b1GalCer\/CD1d-coated nanoparticles (NP) trigger their differentiation into immunoregulatory, IL-10+IL-21-producing Zbtb16<jats:sup>high<\/jats:sup>Maf<jats:sup>high<\/jats:sup>Tbx21<jats:sup>+<\/jats:sup>Gata3<jats:sup>+<\/jats:sup>Rorc<jats:sup>\u2013<\/jats:sup> cells, termed LiNKTR1, expressing a T regulatory type 1 (TR1)-like transcriptional signature. This response is LiNKT-specific, since neither lung nor splenic tissue-resident iNKT cells from \u03b1GalCer\/CD1d-NP-treated mice produce IL-10 or IL-21. Additionally, these LiNKTR1 cells suppress autoantigen presentation, and recognize CD1d expressed on conventional B cells to induce IL-10+IL-35-producing regulatory B (Breg) cells, leading to the suppression of liver and pancreas autoimmunity. Our results thus suggest that LiNKT cells are plastic for further functional diversification, with such plasticity potentially targetable for suppressing tissue-specific inflammatory phenomena.<\/jats:p>","DOI":"10.1038\/s41467-022-30759-w","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T15:10:30Z","timestamp":1654614630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-2141","authenticated-orcid":false,"given":"Channakeshava Sokke","family":"Umeshappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7430-7289","authenticated-orcid":false,"given":"Saswat","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas G. J.","family":"Surewaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9493-1321","authenticated-orcid":false,"given":"Josep","family":"Garnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiswarup","family":"Singha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cort\u00e9s-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"D\u2019Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2835-4244","authenticated-orcid":false,"given":"Paul","family":"Kubes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3469-1586","authenticated-orcid":false,"given":"Pere","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"30759_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2016.01.001","volume":"39","author":"L Gapin","year":"2016","unstructured":"Gapin, L. Development of invariant natural killer T cells. Curr. Opin. Immunol. 39, 68\u201374 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"30759_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac, A., Savage, P. B. & Teyton, L. The biology of NKT cells. Annu Rev. Immunol. 25, 297\u2013336 (2007).","journal-title":"Annu Rev. Immunol."},{"key":"30759_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.it.2012.08.009","volume":"34","author":"L Van Kaer","year":"2013","unstructured":"Van Kaer, L., Parekh, V. V. & Wu, L. Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol. 34, 50\u201358 (2013).","journal-title":"Trends Immunol."},{"key":"30759_CR4","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1172\/JCI72308","volume":"124","author":"D Sag","year":"2014","unstructured":"Sag, D., Krause, P., Hedrick, C. C., Kronenberg, M. & Wingender, G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Investig. 124, 3725\u20133740 (2014).","journal-title":"J. Clin. Investig."},{"key":"30759_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-018-0034-2","volume":"18","author":"CM Crosby","year":"2018","unstructured":"Crosby, C. M. & Kronenberg, M. Tissue-specific functions of invariant natural killer T cells. Nat. Rev. Immunol. 18, 559\u2013574 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"30759_CR6","doi-asserted-by":"publisher","first-page":"19845","DOI":"10.1073\/pnas.0806472105","volume":"105","author":"ML Michel","year":"2008","unstructured":"Michel, M. L. et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl Acad. Sci. USA 105, 19845\u201319850 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30759_CR7","doi-asserted-by":"publisher","first-page":"e1001255","DOI":"10.1371\/journal.pbio.1001255","volume":"10","author":"H Watarai","year":"2012","unstructured":"Watarai, H. et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol. 10, e1001255 (2012).","journal-title":"PLoS Biol."},{"key":"30759_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2015.06.025","volume":"43","author":"YJ Lee","year":"2015","unstructured":"Lee, Y. J. et al. Tissue-specific distribution of iNKT cells impacts their cytokine response. Immunity 43, 566\u2013578 (2015).","journal-title":"Immunity"},{"key":"30759_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ni.3047","volume":"16","author":"L Lynch","year":"2015","unstructured":"Lynch, L. et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 16, 85\u201395 (2015).","journal-title":"Nat. Immunol."},{"key":"30759_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3389\/fimmu.2018.01450","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang, H. & Hogquist, K. A. How lipid-specific T cells become effectors: the differentiation of iNKT subsets. Front. Immunol. 9, 1450 (2018).","journal-title":"Front. Immunol."},{"key":"30759_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fimmu.2018.00519","volume":"9","author":"L Van Kaer","year":"2018","unstructured":"Van Kaer, L. & Wu, L. Therapeutic potential of invariant natural killer T cells in autoimmunity. Front. Immunol. 9, 519 (2018).","journal-title":"Front. Immunol."},{"key":"30759_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2017.09.016","volume":"47","author":"PX Liew","year":"2017","unstructured":"Liew, P. X., Lee, W. Y. & Kubes, P. iNKT cells orchestrate a switch from inflammation to resolution of sterile liver injury. Immunity 47, 752\u2013765 e755 (2017).","journal-title":"Immunity"},{"key":"30759_CR13","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3","volume":"30","author":"Y Osman","year":"2000","unstructured":"Osman, Y. et al. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur. J. Immunol. 30, 1919\u20131928 (2000).","journal-title":"Eur. J. Immunol."},{"key":"30759_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4049\/jimmunol.175.3.1540","volume":"175","author":"M Biburger","year":"2005","unstructured":"Biburger, M. & Tiegs, G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J. Immunol. 175, 1540\u20131550 (2005).","journal-title":"J. Immunol."},{"key":"30759_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.chom.2008.03.009","volume":"3","author":"J Mattner","year":"2008","unstructured":"Mattner, J. et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3, 304\u2013315 (2008).","journal-title":"Cell Host Microbe"},{"key":"30759_CR16","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1073\/pnas.040566697","volume":"97","author":"K Takeda","year":"2000","unstructured":"Takeda, K. et al. Critical contribution of liver natural killer T cells to a mouse model of hepatitis. Proc. Natl Acad. Sci. USA 97, 5498\u20135503 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30759_CR17","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3389\/fimmu.2018.02424","volume":"9","author":"W Huang","year":"2018","unstructured":"Huang, W. et al. The role of CD1d and MR1 restricted T cells in the liver. Front. Immunol. 9, 2424 (2018).","journal-title":"Front. Immunol."},{"key":"30759_CR18","doi-asserted-by":"publisher","first-page":"G1054","DOI":"10.1152\/ajpgi.90464.2008","volume":"296","author":"S Kuboki","year":"2009","unstructured":"Kuboki, S. et al. Distinct contributions of CD4+ T cell subsets in hepatic ischemia\/reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1054\u2013G1059 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"30759_CR19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/hep.22813","volume":"49","author":"O Park","year":"2009","unstructured":"Park, O. et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49, 1683\u20131694 (2009).","journal-title":"Hepatology"},{"key":"30759_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hep.22052","volume":"47","author":"YH Chuang","year":"2008","unstructured":"Chuang, Y. H. et al. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 47, 571\u2013580 (2008).","journal-title":"Hepatology"},{"key":"30759_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nnano.2017.56","volume":"12","author":"S Singha","year":"2017","unstructured":"Singha, S. et al. Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices. Nat. Nanotechnol. 12, 701\u2013710 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"30759_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"30759_CR23","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41467-019-09893-5","volume":"10","author":"CS Umeshappa","year":"2019","unstructured":"Umeshappa, C. S. et al. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nat. Commun. 10, 2150 (2019).","journal-title":"Nat. Commun."},{"key":"30759_CR24","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1172\/JCI130670","volume":"130","author":"CS Umeshappa","year":"2020","unstructured":"Umeshappa, C. S. et al. Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity. J. Clin. Investig. 130, 1823\u20131829 (2020).","journal-title":"J. Clin. Investig."},{"key":"30759_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41587-019-0015-4","volume":"37","author":"P Serra","year":"2019","unstructured":"Serra, P. & Santamaria, P. Antigen-specific therapeutic approaches for autoimmunity. Nat. Biotechnol. 37, 238\u2013251 (2019).","journal-title":"Nat. Biotechnol."},{"key":"30759_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/hep.28641","volume":"64","author":"HR Bae","year":"2016","unstructured":"Bae, H. R. et al. Chronic expression of interferon-gamma leads to mouse autoimmune cholangitis with a female predominance. Hepatology 64, 1189\u20131201 (2016).","journal-title":"Hepatology"},{"key":"30759_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/hep.26380","volume":"58","author":"M Hardtke-Wolenski","year":"2013","unstructured":"Hardtke-Wolenski, M. et al. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells. Hepatology 58, 718\u2013728 (2013).","journal-title":"Hepatology"},{"key":"30759_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.1855","volume":"11","author":"WY Lee","year":"2010","unstructured":"Lee, W. Y. et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat. Immunol. 11, 295\u2013302 (2010).","journal-title":"Nat. Immunol."},{"key":"30759_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.186.10.1663","volume":"186","author":"J Verdaguer","year":"1997","unstructured":"Verdaguer, J. et al. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186, 1663\u20131676 (1997).","journal-title":"J. Exp. Med."},{"key":"30759_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35021081","volume":"406","author":"A Amrani","year":"2000","unstructured":"Amrani, A. et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406, 739\u2013742 (2000).","journal-title":"Nature"},{"key":"30759_CR31","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.4049\/jimmunol.0901059","volume":"183","author":"JM Doisne","year":"2009","unstructured":"Doisne, J. M. et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J. Immunol. 183, 2142\u20132149 (2009).","journal-title":"J. Immunol."},{"key":"30759_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ni.3437","volume":"17","author":"I Engel","year":"2016","unstructured":"Engel, I. et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat. Immunol. 17, 728\u2013739 (2016).","journal-title":"Nat. Immunol."},{"key":"30759_CR33","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.4049\/jimmunol.1000359","volume":"185","author":"M Monteiro","year":"2010","unstructured":"Monteiro, M. et al. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J. Immunol. 185, 2157\u20132163 (2010).","journal-title":"J. Immunol."},{"key":"30759_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ni.2166","volume":"13","author":"PP Chang","year":"2011","unstructured":"Chang, P. P. et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13, 35\u201343 (2011).","journal-title":"Nat. Immunol."},{"key":"30759_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ni.2172","volume":"13","author":"IL King","year":"2011","unstructured":"King, I. L. et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat. Immunol. 13, 44\u201350 (2011).","journal-title":"Nat. Immunol."},{"key":"30759_CR36","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1172\/JCI62739","volume":"122","author":"HS Schipper","year":"2012","unstructured":"Schipper, H. S. et al. Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Investig. 122, 3343\u20133354 (2012).","journal-title":"J. Clin. Investig."},{"key":"30759_CR37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41467-018-02911-y","volume":"9","author":"K Oleinika","year":"2018","unstructured":"Oleinika, K. et al. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells. Nat. Commun. 9, 684 (2018).","journal-title":"Nat. Commun."},{"key":"30759_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366\u2013370 (2014).","journal-title":"Nature"},{"key":"30759_CR39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"R-X Wang","year":"2014","unstructured":"Wang, R.-X. et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633\u2013641 (2014).","journal-title":"Nat. Med."},{"key":"30759_CR40","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ni.2731","volume":"14","author":"YJ Lee","year":"2013","unstructured":"Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. & Hogquist, K. A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146\u20131154 (2013).","journal-title":"Nat. Immunol."},{"key":"30759_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molimm.2015.09.017","volume":"68","author":"R Berga-Bolanos","year":"2015","unstructured":"Berga-Bolanos, R., Zhu, W. S., Steinke, F. C., Xue, H. H. & Sen, J. M. Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells. Mol. Immunol. 68, 484\u2013489 (2015).","journal-title":"Mol. Immunol."},{"key":"30759_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.1176676","volume":"325","author":"RI Nurieva","year":"2009","unstructured":"Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001\u20131005 (2009).","journal-title":"Science"},{"key":"30759_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jconrel.2021.08.043","volume":"338","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicines. J. Control Release 338, 557\u2013570 (2021).","journal-title":"J. Control Release"},{"key":"30759_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/ni.2230","volume":"13","author":"MP Seiler","year":"2012","unstructured":"Seiler, M. P. et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat. Immunol. 13, 264\u2013271 (2012).","journal-title":"Nat. Immunol."},{"key":"30759_CR45","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/intimm\/dxp097","volume":"21","author":"Y Mori","year":"2009","unstructured":"Mori, Y., Kodaka, T., Kato, T., Kanagawa, E. M. & Kanagawa, O. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Int. Immunol. 21, 1291\u20131299 (2009).","journal-title":"Int. Immunol."},{"key":"30759_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0092-8674(00)81299-4","volume":"85","author":"IC Ho","year":"1996","unstructured":"Ho, I. C., Hodge, M. R., Rooney, J. W. & Glimcher, L. H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973\u2013983 (1996).","journal-title":"Cell"},{"key":"30759_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ni.1690","volume":"10","author":"AT Bauquet","year":"2009","unstructured":"Bauquet, A. T. et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167\u2013175 (2009).","journal-title":"Nat. Immunol."},{"key":"30759_CR48","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.4049\/jimmunol.1701134","volume":"199","author":"JD Wheaton","year":"2017","unstructured":"Wheaton, J. D., Yeh, C. H. & Ciofani, M. Cutting edge: c-Maf Is required for regulatory T cells to adopt RORgammat(+) and follicular phenotypes. J. Immunol. 199, 3931\u20133936 (2017).","journal-title":"J. Immunol."},{"key":"30759_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature25500","volume":"554","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 554, 373\u2013377 (2018).","journal-title":"Nature"},{"key":"30759_CR50","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fimmu.2017.01399","volume":"8","author":"JS Yu","year":"2017","unstructured":"Yu, J. S. et al. Differentiation of IL-17-producing invariant natural killer T cells requires expression of the transcription factor c-Maf. Front. Immunol. 8, 1399 (2017).","journal-title":"Front. Immunol."},{"key":"30759_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41590-018-0083-5","volume":"19","author":"L Gabrysova","year":"2018","unstructured":"Gabrysova, L. et al. c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells. Nat. Immunol. 19, 497\u2013507 (2018).","journal-title":"Nat. Immunol."},{"key":"30759_CR52","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S1074-7613(00)80073-4","volume":"10","author":"JI Kim","year":"1999","unstructured":"Kim, J. I., Ho, I. C., Grusby, M. J. & Glimcher, L. H. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10, 745\u2013751 (1999).","journal-title":"Immunity"},{"key":"30759_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41590-018-0274-0","volume":"20","author":"MK Zuberbuehler","year":"2019","unstructured":"Zuberbuehler, M. K. et al. The transcription factor c-Maf is essential for the commitment of IL-17-producing gammadelta T cells. Nat. Immunol. 20, 73\u201385 (2019).","journal-title":"Nat. Immunol."},{"key":"30759_CR54","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1084\/jem.20130791","volume":"211","author":"S Tanaka","year":"2014","unstructured":"Tanaka, S. et al. Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORgammat induction as downstream targets of Stat3. J. Exp. Med. 211, 1857\u20131874 (2014).","journal-title":"J. Exp. Med."},{"key":"30759_CR55","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","volume":"89","author":"W Zheng","year":"1997","unstructured":"Zheng, W. & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587\u2013596 (1997).","journal-title":"Cell"},{"key":"30759_CR56","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/ni.2020","volume":"12","author":"Y Motomura","year":"2011","unstructured":"Motomura, Y. et al. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat. Immunol. 12, 450\u2013459 (2011).","journal-title":"Nat. Immunol."},{"key":"30759_CR57","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.4049\/jimmunol.1401001","volume":"193","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. The cross-priming capacity and direct presentation potential of an autoantigen are separable and inversely related properties. J. Immunol. 193, 3296\u20133307 (2014).","journal-title":"J. Immunol."},{"key":"30759_CR58","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/eji.201041092","volume":"41","author":"N Zietara","year":"2011","unstructured":"Zietara, N., Lyszkiewicz, M., Krueger, A. & Weiss, S. ICOS-dependent stimulation of NKT cells by marginal zone B cells. Eur. J. Immunol. 41, 3125\u20133134 (2011).","journal-title":"Eur. J. Immunol."},{"key":"30759_CR59","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.4049\/jimmunol.0802273","volume":"182","author":"E Bialecki","year":"2009","unstructured":"Bialecki, E. et al. Role of marginal zone B lymphocytes in invariant NKT cell activation. J. Immunol. 182, 6105\u20136113 (2009).","journal-title":"J. Immunol."},{"key":"30759_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","volume":"491","author":"A Yoshizaki","year":"2012","unstructured":"Yoshizaki, A. et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264\u2013268 (2012).","journal-title":"Nature"},{"key":"30759_CR61","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1073\/pnas.0804358105","volume":"105","author":"R Spolski","year":"2008","unstructured":"Spolski, R., Kashyap, M., Robinson, C., Yu, Z. & Leonard, W. J. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 105, 14028\u201314033 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30759_CR62","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2337\/db08-0882","volume":"58","author":"AP Sutherland","year":"2009","unstructured":"Sutherland, A. P. et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58, 1144\u20131155 (2009).","journal-title":"Diabetes"},{"key":"30759_CR63","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.jtauto.2019.100011","volume":"2","author":"FN Mohd Jaya","year":"2019","unstructured":"Mohd Jaya, F. N., Garcia, S. G., Borras, F. E., Chan, G. C. F. & Franquesa, M. Paradoxical role of Breg-inducing cytokines in autoimmune diseases. J. Transl. Autoimmun. 2, 100011 (2019).","journal-title":"J. Transl. Autoimmun."},{"key":"30759_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.immuni.2014.08.017","volume":"41","author":"L Kain","year":"2014","unstructured":"Kain, L. et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 41, 543\u2013554 (2014).","journal-title":"Immunity"},{"key":"30759_CR65","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature03408","volume":"434","author":"J Mattner","year":"2005","unstructured":"Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525\u2013529 (2005).","journal-title":"Nature"},{"key":"30759_CR66","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/ajt.12922","volume":"14","author":"JM Zimmerer","year":"2014","unstructured":"Zimmerer, J. M. et al. Critical role of NKT cells in posttransplant alloantibody production. Am. J. Transplant. 14, 2491\u20132499 (2014).","journal-title":"Am. J. Transplant."},{"key":"30759_CR67","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4049\/jimmunol.1202223","volume":"191","author":"SG Zeng","year":"2013","unstructured":"Zeng, S. G. et al. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro. J. Immunol. 191, 1666\u20131676 (2013).","journal-title":"J. Immunol."},{"key":"30759_CR68","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2017.09.022","volume":"171","author":"R Hebbandi Nanjundappa","year":"2017","unstructured":"Hebbandi Nanjundappa, R. et al. A gut microbial mimic that hijacks diabetogenic autoreactivity to suppress colitis. Cell 171, 655\u2013667 (2017).","journal-title":"Cell"},{"key":"30759_CR69","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1073\/pnas.1131954100","volume":"100","author":"EE Hamilton-Williams","year":"2003","unstructured":"Hamilton-Williams, E. E., Palmer, S. E., Charlton, B. & Slattery, R. M. Beta cell MHC class I is a late requirement for diabetes. Proc. Natl Acad. Sci. USA 100, 6688\u20136693 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30759_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4049\/jimmunol.1300168","volume":"191","author":"S Tsai","year":"2013","unstructured":"Tsai, S., Serra, P., Clemente-Casares, X., Slattery, R. M. & Santamaria, P. Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class II. J. Immunol. 191, 70\u201382 (2013).","journal-title":"J. Immunol."},{"key":"30759_CR71","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","volume":"205","author":"M Holdener","year":"2008","unstructured":"Holdener, M. et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J. Exp. Med. 205, 1409\u20131422 (2008).","journal-title":"J. Exp. Med."},{"key":"30759_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymeth.2017.05.004","volume":"128","author":"BGJ Surewaard","year":"2017","unstructured":"Surewaard, B. G. J. & Kubes, P. Measurement of bacterial capture and phagosome maturation of Kupffer cells by intravital microscopy. Methods 128, 12\u201319 (2017).","journal-title":"Methods"},{"key":"30759_CR73","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696\u2013699 (1995).","journal-title":"J. Hepatol."},{"key":"30759_CR74","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996\u20131006 (2002).","journal-title":"Genome Res."},{"key":"30759_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"30759_CR76","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"30759_CR77","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/nprot.2007.324","volume":"2","author":"MS Cline","year":"2007","unstructured":"Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2, 2366\u20132382 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30759-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:41:36Z","timestamp":1669311696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30759-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30759"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30759-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.Santamaria is founder, scientific officer and stockholder of Parvus Therapeutics. He is inventor on patents on pMHC-based nanomedicines and receives funding from the company. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3279"}}